PMCBD Stock Price, News & Analysis

PMCBD OTC

Company Description

PMCBD (OTC: PMCBD) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector.

This page provides a comprehensive overview of PMCBD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

Latest News

View All

August 2, 2021

—

PharmaCyte Biotech Announces Uplist to The Nasdaq Capital Market and Launch of Public Offering

offering

July 22, 2021

—

PharmaCyte Biotech Provides Update to Nasdaq Listing Efforts and Presents Scientific Publications Supporting Pancreatic Cancer Treatment

July 13, 2021

—

PharmaCyte Biotech Announces Stability Test Results on Cells from Master Cell Bank

PMCBD has 3 recent news articles. Key topics include offering. View all PMCBD news →

SEC Filings

View All

No SEC filings available for PMCBD.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

PMCBD Company Profile & Sector Positioning

PMCBD (PMCBD) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.